• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 20-F filed by Bioceres Crop Solutions Corp.

    10/30/25 4:51:05 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials
    Get the next $BIOX alert in real time by email
    NT 20-F 1 tm2525541d2_nt20f.htm NT 20-F

     

     

     

       

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    FORM 12b-25

    NOTIFICATION OF LATE FILING

       
    (Check One):
    ☐ Form 10-K
    ☒ Form 20-F
    ☐ Form 11-K
    ☐ Form 10-Q
    ☐ Form N-SAR
    ☐ Form N-CSR
    SEC FILE NUMBER
    001-38836
    CUSIP NUMBER
    G1117K114

     

     

        For Period Ended:  June 30, 2025  
    ☐ Transition Report on Form 10-K
    ☐ Transition Report on Form 20-F
    ☐ Transition Report on Form 11-K
    ☐ Transition Report on Form 10-Q
    ☐ Transition Report on Form N-SAR
    For the Transition Period Ended: ____________________
       

     

     

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. 

     

     

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

     

     

     

     

     

    PART I - REGISTRANT INFORMATION

      

      Bioceres Crop Solutions Corp.  
      Full Name of Registrant  
         
       N/A  
      Former Name if Applicable  
         
      Ocampo 210 bis, Predio CCT  
      Address of Principal Executive Office (Street and Number)  
         
      Rosario, Province of Santa Fe, Argentina  
      City, State and Zip Code  

     

      

     

     

     

    PART II - RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

          (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    ☒   (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
        (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

     

    PART III - NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    Bioceres Crop Solutions Corp. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 20-F for the fiscal year ended June 30, 2025 (the “Form 20-F”) within the prescribed period without unreasonable effort or expense to the Company. The delay is due to the additional time required by the Company to complete the evaluation and review of certain disclosures in the Form 20-F, following recent changes in the Company’s Board of Directors and executive management. These leadership transitions have necessitated further coordination and review to ensure the consistency, accuracy, and completeness of the Company’s public disclosures. As a result, these processes have resulted in time constraints that make timely filing impracticable. The Company undertakes to file Form 20-F as soon as practicable and anticipates that it will be filed no later than the fifteenth calendar day following the prescribed filing date.

     

    On September 25, 2025, Jasper Lake delivered a reservation of rights letter to the Company, through counsel (the “Kramer Letter”). In response to the Kramer Letter, the Company delivered a reservation of rights letter to Jasper Lake on September 30, 2025, disputing that any Events of Default have occurred under the Note Purchase Agreements and reinforcing that it is in the best interest of the Company and all of its stakeholders to engage in a productive dialogue with Jasper Lake to address any legitimate concern it may have. The description of the interaction between the Company and Jasper Lake is further detailed in Exhibits 99.1 and 99.2 to the Form 6-K filed with the SEC on October 1, 2025. This document is available on the SEC’s EDGAR system at https://www.sec.gov/Archives/edgar/data/1769484/000110465925095812/tm2527803d1_6k.htm. This situation combined with adverse market conditions and the suspension of credit lines in certain subsidiaries created a context of financial uncertainty. Management is actively pursuing alternatives to address the situation, including new long-term facility or assets disposal, among other, while also evaluating the broader implications for the Company’s structure.

     

    If the dispute with Jasper Lake and the uncertainties regarding the financial condition of the Company remain unresolved at the time that the Company ultimately files the Form 20-F, management anticipates that the consolidated financial statements as of and for the year ended June 30, 2025 will contain an explanatory note indicating uncertainty surrounding the Company’s ability to secure additional financing that would contribute to a material uncertainty that would raise substantial doubt regarding the Company’s ability to continue as a going concern.

     

    SEC 1344 (07-03)   Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

     

     

     

     

    PART IV - OTHER INFORMATION

               
    (1) Name and telephone number of person to contact in regard to this notification
     
      Federico Trucco   +54   341 4861122
      (Name)   (Area Code)   (Telephone Number)
     
    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).    x  Yes     ¨  No
     
    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?   x Yes     ¨  No
     
      If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
       
      The Company is required by Part IV, Item (3) of Form 12b-25 to provide as part of this filing an explanation regarding whether the results of operations the Company expects to report for the year ended June 30, 2025 will reflect significant changes from its results of operations for the year June 30, 2024. While the Company requires additional time to prepare and review disclosures in the Form 20-F, the Company expects that any significant changes in its results of operations for the year ended June 30, 2025 as compared to the results of operations for the year ended June 30, 2024 will be consistent with those disclosed in its financial and operational results for the fiscal fourth quarter ended June 30, 2025 and for the year ended June 30, 2025, furnished to the SEC on a current report on Form 6-K on September 9, 2025.

     

     

     

     

     

     

     

     

    Bioceres Crop Solutions Corp.

    (Name of Registrant as Specified in Charter)

     

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

    Date: October 30, 2025

     

     

     

     

    By:  /s/ Federico Trucco                      

    Name: Federico Trucco

    Title: Chief Executive Officer

     

     

     

      

     

     

     

     

    Get the next $BIOX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIOX

    DatePrice TargetRatingAnalyst
    10/22/2025Outperform → Perform
    Oppenheimer
    9/10/2025$2.50Buy → Hold
    Canaccord Genuity
    7/19/2024$17.00Buy
    Canaccord Genuity
    7/2/2024$15.00Buy
    ROTH MKM
    4/6/2023$15.00Outperform
    Oppenheimer
    9/30/2022$22.50Buy
    Canaccord Genuity
    10/8/2021$21.00Buy
    ROTH Capital
    More analyst ratings

    $BIOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bioceres downgraded by Oppenheimer

    Oppenheimer downgraded Bioceres from Outperform to Perform

    10/22/25 10:10:01 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Bioceres from Buy to Hold and set a new price target of $2.50

    9/10/25 7:58:04 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Bioceres with a new price target

    Canaccord Genuity resumed coverage of Bioceres with a rating of Buy and set a new price target of $17.00

    7/19/24 8:32:10 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

    Total revenues were $77.5 million in 1Q26 Net loss was $7.5 million and Adjusted EBITDA1 was $13.6 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues were

    11/12/25 5:15:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2025. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. The conference call will be ac

    10/30/25 8:30:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4® Wheat in the U.S.

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) and the Colorado Wheat Research Foundation (CWRF) today announced a strategic collaboration to jointly develop and commercialize HB4® wheat in the United States. The agreement combines Bioceres' proprietary HB4® technology, with CWRF's leadership in U.S. wheat innovation to create a next generation wheat production system. This system is designed to integrate climate resilience and environmentally responsible weed management, delivering greater productivity for growers and improved supply stability for customers. As part of the collaboration, Bioceres will grant CWRF exclusive, sublicensable rights to the HB4® trait in the U.S. territory. CWRF

    9/23/25 7:00:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    SEC Filings

    View All

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    11/13/25 7:44:52 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    11/12/25 1:01:27 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form 20-F filed by Bioceres Crop Solutions Corp.

    20-F - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    11/10/25 12:26:23 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Financials

    Live finance-specific insights

    View All

    Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

    Total revenues were $77.5 million in 1Q26 Net loss was $7.5 million and Adjusted EBITDA1 was $13.6 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues were

    11/12/25 5:15:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2025. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. The conference call will be ac

    10/30/25 8:30:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results

    Total revenues were $74.7 million in 4Q25 and $335.3 million in FY25 FY25 results reflect challenging year amid ag sector headwinds and macro pressures in Argentina Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted.

    9/9/25 6:00:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Bioceres Crop Solutions Corp.

    SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    10/23/24 2:32:38 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp.

    SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    9/20/24 9:09:41 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp. (Amendment)

    SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    3/25/24 8:58:35 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials